CSIMarket Company Name, Ticker, Suppliers, else..


Nektar Therapeutics  (NASDAQ: NKTR)
Other Ticker:  
 

Nektar Therapeutics

NKTR's Fundamental analysis



Nektar Therapeutics's sales fell by -51.66 % in the first quarter of 2025 from the same quarter a year ago.

Major Pharmaceutical Preparations industry recorded growth of revenues by 4.5 %

Nektar Therapeutics net loss increased from $-37 millions, to $-51 millions in first quarter of 2025,

• More on NKTR's Growth


Nektar Therapeutics
realized a net loss in trailing twelve months.

Nektar Therapeutics realized cash reduction of $ -0.05 per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 1.66.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.18.


• More on NKTR's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 122,712
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) 0.07

Nektar Therapeutics
realized net loss in trailing twelve months.

Nektar Therapeutics realized cash outflow of $ -0.05per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 1.66.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.18.

Nektar Therapeutics Price to Book Ratio is at 10.52 lower than Industry Avg. of 33.19. and higher than S&P 500 Avg. of 0.01

• More on NKTR's Valuation

•  Market Capitalization (Millions $) 144
•  Shares Outstanding (Millions) 211
•  Employees 711
•  Revenues (TTM) (Millions $) 87
•  Net Income (TTM) (Millions $) -133
•  Cash Flow (TTM) (Millions $) -10
•  Capital Exp. (TTM) (Millions $) -1
•  Total Debt (Millions $) -
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 122,712
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) -
•  Tangible Book Value (Per Share $) 0.07

•  Market Capitalization (Millions $) 144
•  Shares Outstanding (Millions) 211
•  Employees 711
•  Revenues (TTM) (Millions $) 87
•  Net Income (TTM) (Millions $) -133
•  Cash Flow (TTM) (Millions $) -10
•  Capital Exp. (TTM) (Millions $) -1





  Ratio
•   Capital Ratio (MRQ) 3.24
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) 17.65
•  Asset Turnover Ratio (TTM) 0.3
•  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com